Saturday 17 October 2026
Export ECOR’s income statement to Excel — free account
electroCore, Inc.
ECOR Healthcare Medical Devices
electroCore, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 27.2% from fiscal 2024. In the quarter to June 2026, revenue grew 28.0%, EPS grew 25.0% and free cash flow fell 443.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
7.85
0.50
−5.99%
Follow ECOR
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 | 4 | 6 | 4 | 4 | 6 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 12.93 | (4.27) | (1.86) | (1.23) | (8.87) | (14.58) | (6.79) | (13.54) |
P/S ratio |
0.00 | 0.00 | 184.57 | 19.55 | 17.41 | 6.33 | 2.20 | 2.05 | 4.82 | 1.19 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(729.23) | (6.24) | 8.67 | (10.72) | (9.20) | (1.47) | (19.40) | (38.07) | (29.29) | (36.67) |
Beneish M-Score |
— | (1.34) | 0.67 | 14.39 | (3.93) | (2.51) | (3.70) | (3.21) | (2.44) | (4.52) |
P/Operating CF |
0.00 | 0.00 | (15.05) | (5.13) | (17.00) | (7.93) | (4.70) | (10.54) | (96.65) | (24.73) |
P/B ratio |
0.00 | 0.00 | 2.77 | 1.88 | 2.57 | 0.94 | 1.10 | 4.42 | 16.08 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 2.77 | 1.88 | 2.57 | 0.94 | 1.10 | 4.42 | 16.08 | 0.00 |
EV/Sales |
0.00 | 0.00 | 119.69 | 10.33 | 11.54 | 0.11 | 0.19 | 1.43 | 4.36 | 1.04 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.11) | (0.11) | (2.52) | (0.55) | (2.01) | (0.04) | (0.10) | (1.57) | (15.79) | (4.05) |
EV/FCF |
(0.11) | (0.11) | (2.51) | (0.55) | (2.01) | (0.04) | (0.10) | (1.55) | (15.34) | (4.02) |
Quick Ratio |
0.11 | 6.09 | 9.73 | 2.69 | 3.89 | 6.40 | 2.61 | 1.39 | 1.48 | 1.11 |
Current Ratio |
0.12 | 6.38 | 10.28 | 2.90 | 4.26 | 6.84 | 3.01 | 1.76 | 1.78 | 1.38 |
Net Debt/EBITDA |
(0.26) | 1.79 | 1.25 | 0.49 | 0.89 | 1.74 | 0.78 | 0.58 | 1.07 | 0.40 |
Debt/Assets |
666.66% | 5.71% | 0.00% | 4.00% | 3.48% | 1.63% | 2.52% | 0.00% | 0.00% | 35.39% |
Debt/Equity |
(0.55) | 0.07 | 0.00 | 0.06 | 0.05 | 0.02 | 0.04 | 0.00 | 0.00 | (3.87) |
Asset Turnover |
0.01 | 0.04 | 0.02 | 0.04 | 0.10 | 0.15 | 0.25 | 0.78 | 1.38 | 1.64 |
Operating CF/Net income |
0.84 | 0.00 | 1.36 | 1.00 | 0.85 | 0.79 | 0.75 | 0.78 | 0.58 | 0.59 |
Capex/Depreciation |
0.00 | (0.02) | 0.65 | 0.25 | 0.00 | 0.00 | 0.00 | (0.21) | 0.00 | (0.10) |
Interest Coverage |
(64.04) | (4.07) | (54.21) | (47.48) | (266.97) | (1,873.18) | (79.70) | — | (31.26) | (22.29) |
| 20.83% | 0.00% | 298.10% | (99.14%) | (96.87%) | (57.11%) | (82.49%) | (153.57%) | (158.63%) | (478.70%) | |
| (78.97%) | 0.00% | (61.56%) | (82.87%) | (70.20%) | (46.32%) | (65.58%) | (92.19%) | (65.00%) | (71.37%) | |
ROIC |
0.00% | 0.00% | 0.00% | (1,275.76%) | (731.55%) | (471.20%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
439.47% | 0.00% | (52.57%) | (254.59%) | (121.08%) | (53.47%) | (156.31%) | (295.44%) | (162.69%) | (297.15%) |
Average Days of Receivables |
35.48 | 46.42 | 98.36 | 75.75 | 28.24 | 29.33 | 17.04 | 16.33 | 19.81 | 11.70 |
Research and Development Expense of Revenue |
3,137.07% | 964.99% | 1,255.41% | 414.27% | 120.18% | 46.52% | 64.25% | 33.19% | 9.37% | 8.54% |
Selling, General and Administrative Expense of Revenue |
2,821.45% | 2,231.26% | 4,280.12% | 1,481.92% | 624.78% | 395.76% | 283.17% | 169.52% | 123.89% | 119.27% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
56.12% | 56.97% | 765.31% | 162.98% | 97.91% | 60.41% | 31.22% | 10.59% | 7.43% | 6.03% |
Graham Net Nets |
0.00 | 0.00 | 0.36 | 0.34 | 0.28 | 0.91 | 0.72 | 0.17 | 0.03 | (0.12) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.73 |
Earnings Yield |
(9.22%) | (9.22%) | (18.85%) | (96.18%) | (41.01%) | (51.40%) | (120.76%) | (59.63%) | (9.99%) | (36.75%) |
Free Cash Flow Yield |
0.00% | 0.00% | (25.86%) | (96.58%) | (33.06%) | (39.68%) | (88.58%) | (45.17%) | (5.90%) | (21.67%) |
Revenue per Share |
0.03 | 0.00 | 0.51 | 1.22 | 1.34 | 1.38 | 1.82 | 2.91 | 3.37 | 3.78 |
Operating CF per Share |
(1.32) | 0.00 | (24.14) | (23.00) | (7.71) | (3.45) | (3.52) | (2.66) | (0.93) | (0.97) |
Capex per Share |
0.00 | 0.00 | (0.14) | (0.04) | 0.00 | 0.00 | 0.00 | (0.04) | 0.00 | (0.01) |
Free Cash Flow per Share |
(1.32) | 0.00 | (24.28) | (23.03) | (7.71) | (3.45) | (3.52) | (2.70) | (0.93) | (0.97) |
Cash per Share |
0.04 | 0.00 | 35.13 | 12.28 | 8.70 | 8.79 | 3.80 | 1.92 | 1.63 | 1.37 |
Shareholders Equity per Share |
(0.75) | 0.00 | 33.91 | 12.71 | 9.09 | 9.29 | 3.61 | 1.35 | 1.01 | (0.20) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.75) | 0.00 | 33.91 | 12.71 | 9.09 | 9.29 | 3.61 | 1.35 | 1.01 | (0.20) |
Free Cash Flow |
(13.23) | (25.48) | (47.39) | (45.14) | (20.05) | (13.63) | (16.64) | (14.87) | (6.95) | (8.25) |
Working Capital |
(3.63) | 32.91 | 65.63 | 17.39 | 19.17 | 32.06 | 14.13 | 6.17 | 7.15 | 4.32 |
Capital Expenditures |
— | (0.15) | (0.28) | (0.07) | — | — | — | (0.21) | — | (0.07) |
Net Current Asset Value |
(7.65) | 32.61 | 65.38 | 15.97 | 17.19 | 31.36 | 13.50 | 5.63 | 3.37 | (4.71) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.19 | 0.28 | 0.03 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
12.20 | 36.25 | (1.13) | (0.81) | 1.76 | 3.56 | 10.96 | 4.72 | 4.81 | 1.66 |
Cash ROIC |
445.00% | (35.28%) | (35.17%) | (89.60%) | (42.33%) | (18.92%) | (46.66%) | (82.53%) | (35.16%) | (49.99%) |
Accounts Receivable Turnover |
3.97 | 12.69 | 5.36 | 6.26 | 9.12 | 15.39 | 20.48 | 28.68 | 24.17 | 26.76 |
Accounts Payable Turnover |
0.06 | 0.25 | 0.33 | 0.29 | 0.48 | 0.92 | 1.05 | 1.31 | 1.90 | 1.87 |
Inventory Turnover |
0.66 | 2.76 | 0.51 | 0.81 | 1.97 | 1.24 | 0.97 | 1.35 | 1.97 | 2.57 |
Average Days of Payables |
9,726.94 | 591.60 | 1,702.26 | 1,643.29 | 436.68 | 247.20 | 480.87 | 281.56 | 176.18 | 233.24 |
Days of Inventory on Hand |
143.11 | 230.76 | 1,229.53 | 281.08 | 184.11 | 358.68 | 447.67 | 281.17 | 161.62 | 140.27 |
Average Receivables |
0.06 | 0.06 | 0.19 | 0.38 | 0.38 | 0.35 | 0.42 | 0.56 | 1.04 | 1.20 |
Average Payables |
2.07 | 2.07 | 1.77 | 3.95 | 3.64 | 1.51 | 1.53 | 2.15 | 2.00 | 2.27 |
Average Inventory |
0.19 | 0.19 | 1.14 | 1.42 | 0.88 | 1.12 | 1.67 | 2.07 | 1.92 | 1.65 |
Average Assets |
19.93 | 19.93 | 56.37 | 54.48 | 33.49 | 37.18 | 33.79 | 20.43 | 18.29 | 19.57 |
Average Common Equity |
(75.56) | (75.26) | (11.64) | 45.54 | 24.27 | 30.15 | 26.87 | 12.26 | 7.49 | 2.92 |
Columns are period end dates